Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.
about
Genomics, personalized medicine, and pediatricsEpigenetics of Alzheimer's disease and frontotemporal dementiaBeyond the genome: epigenetic mechanisms in lung remodelingEffects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disordersPreoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.Biology of colorectal cancer.Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.Novel epigenetic determinants of type 2 diabetes in Mexican-American familiesTargeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.Epigenetic modulation of the immune function: a potential target for tolerancePhospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomasALS and FTD: an epigenetic perspective.Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells.The epigenetic basis of cellular plasticity.WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection.
P2860
Q26991570-92C7C405-680B-4EA0-BAC2-4BDD50EA3552Q27010153-A86DB8F1-4D95-45C4-A194-956C91C3A0DDQ27021767-A5C0F7D2-A387-45E3-9641-8D14F07AAF59Q28822036-E9E0CCAC-4CC1-4361-BD2A-3269E43B9404Q34432882-B1857711-7C1E-405A-9CB7-26344582B518Q34669618-39C669DA-ABBF-448D-A47D-2AA81ABB96A6Q35820972-666C1DB2-6179-41AE-BB28-01619C4E1F2BQ35999273-1FDF83DC-29DC-4D15-A99F-8F521FCBD605Q36544024-E32CAA69-BBC9-4EEA-BBDE-220F63DAE079Q37510740-B5A60E9D-80AC-4EA8-8350-7EEDF192D125Q37719054-8E0B5AED-DBEB-4335-A477-F93468983993Q38117237-BA437F50-1E72-4572-A663-21868F247737Q38663683-A698EB8E-2283-47E2-A4F6-B742664E85E9Q38860456-22E0FC4D-321B-408F-9BAE-E29440AA40F2Q40751870-1B5BEC05-9DC2-46C4-90F5-7FEC5E175E2DQ50136682-EF25649C-D5B9-4E1A-A043-558D430A1C46Q54638455-06574A54-16EE-4E7F-AB38-169A108E5424Q54679094-116A0F56-FB2B-45EB-BCB5-FB626707E7BD
P2860
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Epigenetic therapy: use of age ...... hylation in cancer management.
@ast
Epigenetic therapy: use of age ...... hylation in cancer management.
@en
type
label
Epigenetic therapy: use of age ...... hylation in cancer management.
@ast
Epigenetic therapy: use of age ...... hylation in cancer management.
@en
prefLabel
Epigenetic therapy: use of age ...... hylation in cancer management.
@ast
Epigenetic therapy: use of age ...... hylation in cancer management.
@en
P2860
P356
P1476
Epigenetic therapy: use of age ...... hylation in cancer management.
@en
P2093
Allen S Ho
Timothy A Chan
P2860
P304
P356
10.2147/OTT.S34680
P407
P50
P577
2013-03-21T00:00:00Z